Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Peginterferon Lambda and Lonafarnib Boosted With Ritonavir 48-Week Combination Therapy for Delta Hepatitis

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · 2024
ClinicalTrials.gov · Datasets · License: Public Domain · 2024
Open Source ↗
chronic hepatitis delta, hepatitis d, pegylated interferon lambda, sustained virological response, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 866414
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.